Skip to content
Main Navigation
Contact Us
About
Our Company
Executive Team
Board of Directors
Scientific Founders
Technology
Bacteriophage background
Phage therapy
Biomarker discovery
Pipeline
Investors
Newsroom
Publications
Careers
+972-72-3942377
info@biomx.com
Connect with us on LinkedIn
Newsroom
News
Press Releases
Events
Year, latest to oldest
Year, oldest to latest
Feb 11, 2021
Fierce Pharma - BiomX hails clinical data as first for oral phage delivery
Feb 10, 2021
IDB News Today - Phage Therapy BX002 Shows Promise in First-in-human Trial
Dec 15, 2020
Solebury Trout Talks - Jonathan Solomon, BiomX - Part of the Nametag Series
Dec 3, 2020
Cystic Fibrosis News Today - BiomX Testing Potential Therapy for CF Lung Infections
Nov 24, 2020
BioSpace: From Acne to Cancer, BiomX Infects Bad Bacteria with Modified Viruses
Oct 9, 2020
Bioconvergence – The next big thing from Israel
Apr 23, 2020
Bioentrepreneur - In conversation with four startup CEOs
Jan 29, 2020
Nature - Fighting cancer with microbes
Oct 18, 2020
BiomX Reports Third Quarter 2020 Financial Results and Announces Expanded Portfolio of Phage Therapy Candidates
Nov 20, 2019
BiomX Presents Preclinical Results of Phage Targeting Klebsiella pneumoniae for Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
Dec 12, 2020
Jefferies 2020 Virtual London Healthcare Conference
Sorry, there are no items that match your search.
Please refine your search and try again.
Sign up for the latest updates
Join our mailing list to receive company updates
delivered to your inbox
Join the list
Reach Us
7 Pinhas Sapir St. Floor 2
Ness Ziona 7414002
Israel
+972-72-3942377
info@biomx.com
Connect with us on LinkedIn